Quest Diagnostics-Nichols Insitute
15
1
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.3%
2 terminated/withdrawn out of 15 trials
77.8%
-8.7% vs industry average
13%
2 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
BRCA Founder OutReach (BFOR) Study
Role: collaborator
Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery
Role: collaborator
Vitamin D for COVID-19 Trial
Role: collaborator
Trial of Pistachio Consumption in Older Adults
Role: collaborator
The Miami Heart Study at Baptist Health South Florida
Role: collaborator
Wellness Program Outreach and Effectiveness
Role: collaborator
Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss
Role: lead
Assay to Measure Beta Blocker Adherence
Role: collaborator
Prospective Electronic Polygenic Risk Study
Role: collaborator
Prospective Electronic Polygenic Risk Study - Second Phase
Role: collaborator
Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals
Role: collaborator
Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Role: collaborator
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Role: collaborator
THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring
Role: collaborator
ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid
Role: collaborator
All 15 trials loaded